France Recommends AstraZeneca Vaccine Only For People Up To 65

(Alliance News) - The top French health authority on Tuesday cleared AstraZeneca PLC's Covid-19 ...

Alliance News 2 February, 2021 | 5:11PM
Email Form Facebook Twitter LinkedIn RSS

(Alliance News) - The top French health authority on Tuesday cleared AstraZeneca PLC's Covid-19 vaccine for use, but advised against giving it to people over 65.

The decision echoes an earlier verdict by Swedish authorities, but is at odds with the EU which last week approved the vaccine for adults of all ages.

France's HAS health authority also said that pharmacists would be authorised to administer the jabs produced by the Anglo-Swedish firm.

Tuesday's conditional backing for the vaccine comes days after President Emmanuel Macron told reporters that the vaccine was "quasi ineffective for people over 65."

Germany and Italy have also said that other vaccines should be given priority for the elderly.

The age controversy compounds a row over a shortfall in deliveries from AstraZeneca that has forced the EU to recalibrate its vaccination strategy.

The EU Commission said the firm had been able to guarantee just 25% of the more than 100 million doses promised, but on Sunday officials said the number would be boosted to 40 million.

Unlike vaccines by Pfizer Inc-BioNTech SE and Moderna Inc, the one made by AstraZeneca can be stored long-term in ordinary refrigeration units.

However its efficacy is reported at just 60%, compared with more than 90% for the rival coronavirus vaccines introduced earlier.

source: AFP

Copyright 2021 Alliance News Limited. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
AstraZeneca PLC 10,926.00 GBX -0.89

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures